Patrones de tratamiento farmacológico para el episodio maníaco en la práctica clínica. Resultados de la muestra española en el estudio EMBLEM

Montoya, A.; Sánchez-Toledo, J. Pérez; Gilaberte, I.; González-Pinto, A.; Haro, J. M.; Vieta, E.; Tohen, M.
September 2007
Actas Espanolas de Psiquiatria;sep2007, Vol. 35 Issue 5, p315
Academic Journal
Introduction. Although treatment for mania has been studied extensively in randomized clinical trials, there are few data that address how these patients are truly managed in clinical, functional, and economic terms in the psychiatric practice in Spain. Objective. To determine prescribing patterns in Spain on the basis of the Spanish sample of bipolar patients in manic or mixed phase included as part of the pan-European EMBLEM Study. Method. The EMBLEM Study recruited 3,681 patients, 312 of whom (8.47%) were included in Spain. Patients had to be adults with a diagnosis of bipolar disorder who were initiating treatment for a manic phase. They underwent evaluation using the Spanish versions of scales that measure severity of mania (the Young Mania Rating Scale, CGI-BP and the Hamilton Scale) and functional level (LCM, SLICE of LIFE). Information was collected regarding drug and treatment adherence variables. Results. Prior to being admitted into the study, 42% of the patients were receiving polytherapy, 35% were on monotherapy, and 23% were not taking any medication whatsoever. Forty percent of the patients presented partial or total non-compliance with the treatment prescribed. During the first stage of the study, in the case of single-drug treatment, acute management for mania consisted of mean daily doses of 25 mg of olanzapine, 6.6 mg of risperidone, 9.5 mg of haloperidol, 165 mg of lamotrigine, 938.5 mg of valproate, and 909 mg of lithium, whereas when combined therapy was used, the following doses were used: olanzapine, 22.1 mg; risperidone, 7.3 mg; haloperidol, 12.3 mg; lamotrigine, 175.1 mg; valproate, 1,038.4 mg, and lithium, 1012.6 mg. Of those patients who were on monotherapy at the beginning of the study 51% were treated with a single drug, whereas 48 % were receiving polytherapy. Among the participants who were receiving combined treatment when they began the study, almost all of them, 94 %, were prescribed combined treatment. In the case of the hospitalized patients who made up 88% of the sample, the vast majority, 92%, had improved by the time the study was completed. Mean time to release from hospital was 24 days. Discussion. In Spain, treatment for mania is essentially based on combined treatments, hospitalization, and anti-mania drugs that are prescribed at somewhat higher doses than those recommended in the corresponding prescribing information documents, which indicates that the clinical reality of this entity is far more complex than clinical trials conducted in experimental conditions suggest.


Related Articles

  • Quetiapine.  // Reactions Weekly;7/8/2006, Issue 1109, p17 

    The article discusses a case report on phobic disorders in a patient with bipolar I disorder. The patient developed a phobic disorder during treatment with quetiapine to treat mania and prevent extrapyramidal symptoms. The dosage of quetiapine taken by the patient is mentioned, as well as her...

  • Clonidine. An effective anti-manic agent? Maguire, J.; Singh, A.N. // British Journal of Psychiatry;Jun87, Vol. 150, p863 

    Three patients suffering from bipolar affective disorder, manic phase, and who were resistant to conservative treatment were successfully treated with clonidine. This would support the nor-adrenergic hyperactivity theory of mania. The rapidity of action of clonidine and its lack of relatively...

  • Antipsikotiklerin Bipolar Bozuklukta Kullanımı. Tuğlu, Cengiz // Klinik Psikofarmakoloji Bulteni;Dec2008 Supplement, Vol. 18, pS50 

    Antipsychotics are commonly used in bipolar disorders both for the treatment of acute episodes and of maintenance. However, the use of typical antipsychotics in bipolar episodes is associated with a number of limitations. Most of the second generation antipsychotics have been found effective in...

  • Will the child with mania please stand up? Carlson, Gabrielle A. // British Journal of Psychiatry;Mar2011, Vol. 198 Issue 3, p171 

    Rates of bipolar disorder in any sample will depend on the sample studied, the interview used, with whom, how the information is integrated, the criteria applied, and the conceptualisation of a manic episode and its symptoms. A cross-national diagnostic study is needed to determine the...

  • Prediction of transition from common adolescent bipolar experiences to bipolar disorder: 10-year study. Tijssen, Marijn J. A.; Van Os, Jim; Wittchen, Hans-Ulrich; Lieb, Roselind; Beesdo, Katja; Mengelers, Ron; Wichers, Marieke // British Journal of Psychiatry;Feb2010, Vol. 196 Issue 2, p102 

    Background: Although (hypo)manic symptoms are common in adolescence, transition to adult bipolar disorder is infrequent.Aims: To examine whether the risk of transition to bipolar disorder is conditional on the extent of persistence of subthreshold affective...

  • Gilles de la Tourette syndrome and mania in an adolescent. Bleich, A.; Bernout, E.; Apter, A.; Tyano, S. // British Journal of Psychiatry;Jun85, Vol. 146, p664 

    The case is presented of a twelve-year-old boy suffering simultaneously from Tourette Syndrome (TS) and a manic episode. The problems of this unique clinical association are discussed from the point of view of differential diagnosis, treatment, and possible biochemical basis. The case also...

  • Unipolar mania reconsidered: evidence from an elderly cohort. Shulman, Kenneth I.; Tohen, Mauricio; Shulman, K I; Tohen, M // British Journal of Psychiatry;Apr94, Vol. 164, p547 

    Earlier studies have failed to differentiate the unipolar manic subtype from bipolar patients with both manic and depressive episodes. This retrospective cohort study of 50 elderly manic in-patients identified six patients (12%) who met strict criteria for a course of unipolar mania. Significant...

  • Combined chlorpromazine and electroconvulsive therapy in mania. Sikdar, Sudip; Kulhara, Parmanand; Avasthi, Ajit; Singh, Hariwir; Sikdar, S; Kulhara, P; Avasthi, A; Singh, H // British Journal of Psychiatry;Jun94, Vol. 164, p806 

    We report the efficacy of combined chlorpromazine and electroconvulsive therapy (ECT) in the treatment of mania. Two groups of 15 manic patients received eight ECT sessions either actual or simulated, in a double-blind, controlled study. All patients also received 600 mg of chlorpromazine daily...

  • Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland China. Zuowei Wang; Keming Gao; Wu Hong; Mengjuan Xing; Zhiguo Wu; Jun Chen; Chen Zhang; Chengmei Yuan; Jia Huang; Daihui Peng; Yong Wang; Weihong Lu; Zhenghui Yi; Xin Yu; Jingping Zhao; Yiru Fang // BMC Psychiatry;2014, Vol. 14 Issue 1, p1 

    Background With the recent attention to evidence-based medicine in psychiatry, a number of treatment guidelines for bipolar disorders have been published. This survey investigated prescribing patterns and predictors for guideline disconcordance in the acute treatment of a manic and mixed episode...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics